Transient and Distortion Product Otoacoustic Emissions (TEOAE & DPOAE)

Transient and Distortion Product Otoacoustic Emissions

Otoacoustic emissions (OAEs) are low-intensity acoustic signals generated by the healthy cochlea and measured in the external auditory canal. First discovered by David Kemp in 1978, OAEs transformed clinical audiology from a discipline reliant entirely on behavioral responses and macro-neuroelectric potentials into one capable of isolating cellular-level mechanical processing within the organ of Corti. Today, OAE assessment is an indispensable component of the audiological test battery, serving vital roles in universal newborn hearing screening, ototoxicity surveillance, differential diagnosis of sensory versus neural hearing impairments, and objective verification of non-organic hearing loss.

---

Biophysical Origin & Cochlear Mechanics

The generation of otoacoustic emissions relies on the active micromechanical properties of the outer hair cells (OHCs) located in the organ of Corti. Unlike inner hair cells (IHCs), which function almost exclusively as sensory transducers converting mechanical shearing into afferent neural impulses along Cranial Nerve VIII, outer hair cells serve as active mechanical effectors.

Outer Hair Cell Electromotility & Prestin

The physical engine of the cochlear amplifier is somatic electromotility—the rapid elongation and contraction of the OHC cell body in response to electrical polarizations across its plasma membrane. This motile process is driven by prestin (encoded by the SLC26A5 gene), a specialized motor protein densely packed within the lateral plasma membrane of OHCs (at densities exceeding $5000-7000\,\text{molecules/}\mu\text{m}^2$).

1. Mechanoelectrical Transduction: Acoustic pressure waves deflect the basilar membrane, causing stereocilia shearing against the tectorial membrane. Deflection toward the tallest stereocilia opens mechanically gated ion channels at the stereocilia tips.
2. Potassium Influx & Depolarization: Driven by the massive $+80\,\text{mV}$ endocochlear potential of the scala media, potassium ions ($K^+$) flood into the OHC, depolarizing the cell from its resting potential of approximately $-70\,\text{mV}$.
3. Prestin Conformational Change: Depolarization causes chloride anions ($Cl^-$) bound to prestin to shift outward, inducing a conformational change in prestin that contracts the longitudinal axis of the OHC cell body.
4. Hyperpolarization & Elongation: Deflection in the opposite direction closes tip links, leading to hyperpolarization and longitudinal somatic elongation.

This cycle occurs on a cycle-by-cycle basis up to extremely high acoustic frequencies ($>20-30\,\text{kHz}$), far exceeding the mechanical limitations of classical actin-myosin cytoskeleton contraction.

The Nonlinear Cochlear Amplifier

The mechanical energy injected back into the cochlear partition by OHC electromotility is known as the cochlear amplifier. It produces two profound physiological effects:

• Sensitivity Enhancement: Adds $40-50\,\text{dB}$ of active gain to low- and moderate-intensity sounds. Without OHC function, hearing thresholds drop to moderate-to-severe sensorineural hearing loss levels ($50-60\,\text{dB HL}$).
• Sharpening of Frequency Tuning: Counteracts viscous damping by cochlear fluids, converting a broad, passive hydrodynamic traveling wave (as described by Georg von Békésy) into a sharply tuned, highly localized displacement peak along the basilar membrane.

Because the cochlear amplifier is an active, saturating system, its mechanical response is inherently nonlinear. This nonlinearity generates harmonic and intermodulation distortion products whenever multiple frequencies stimulate overlapping basilar membrane segments.

Reverse Middle Ear Transmission

For cochlear mechanical vibrations to be detected as sound pressure waves in the external auditory canal, they must propagate in reverse: $\text{Basilar Membrane Vibration} \longrightarrow \text{Perilymph} \longrightarrow \text{Stapes Footplate} \longrightarrow \text{Incus and Malleus} \longrightarrow \text{Tympanic Membrane} \longrightarrow \text{Ear Canal Air}$

Because the middle ear is an acoustic impedance-matching system optimized for forward transmission (air to fluid), reverse transmission encounters significant acoustic impedance and mechanical attenuation (typically $10-15\,\text{dB}$ of attenuation in normal ears). Consequently:

• Any pathology affecting the conductive apparatus—including cerumen occlusion, negative middle ear pressure, otitis media with effusion, ossicular fixation (otosclerosis), or ossicular discontinuity—imposes a two-way attenuation penalty. It attenuates the incoming acoustic stimulus on its forward path and further attenuates the outgoing emission on its reverse path.
• Even subtle middle ear dysfunction (e.g., tympanometric peak pressure of $-150\,\text{daPa}$ or early secretory fluid) frequently obliterates measurable OAEs, even when cochlear outer hair cell function is pristine.

---

Classification of Otoacoustic Emissions

Otoacoustic emissions are categorized into two primary classes based on the presence or absence of an external acoustic evoking stimulus.

Spontaneous OAEs (SOAEs)

SOAEs are continuous, narrowband acoustic signals emitted by the cochlea in the absence of external stimulation. Although they reflect sharp, localized outer hair cell tuning, they have negligible diagnostic utility because their absence is completely normal in $30-50\%$ of healthy ears. Furthermore, SOAEs rarely correlate with subjective tinnitus, although rare cases of audible objective tinnitus arise from high-amplitude SOAEs.

Stimulus-Frequency OAEs (SFOAEs)

SFOAEs occur at the exact same frequency as the continuous pure-tone stimulus driving the ear. Because the evoking tone and the emission overlap in both frequency and time, separating the microscopic emission from the massive stimulus artifact requires sophisticated phase-cancellation or suppression paradigms. SFOAEs provide pristine insights into cochlear reflection mechanics but remain largely confined to research laboratories.

---

Transient Evoked OAEs (TEOAE): Clinical Protocol & Acquisition

TEOAEs are acoustic echoes elicited by brief, transient acoustic stimuli, most commonly rectangular electrical pulses delivered to an acoustic transducer.

Stimulus Parameters & Presentation Modes

• Stimulus: Broadband click ($80\,\mu\text{s}$ duration), delivering uniform acoustic energy across the $500-5000\,\text{Hz}$ spectrum.
• Presentation Level: $80-84\,\text{dB}$ peak equivalent SPL (peSPL). Higher stimulus levels risk eliciting middle ear muscle acoustic reflexes or driving the transducer into nonlinear mechanical distortion, which mimics biological emissions.
• Non-Linear Differential Protocol (Kemp Protocol): In linear acquisition, acoustic ringing of the transducer in the ear canal completely obscures the early part of the biological response ($<5\,\text{ms}$). To eliminate stimulus artifact, standard clinical systems employ a four-click non-linear differential sequence:
  • Three clicks of equal amplitude ($A$) and positive polarity are presented: $+A, +A, +A$.
  • A fourth click of triple amplitude ($3A$) and inverted polarity is presented: $-3A$.
  • When the four responses are averaged together: $(+A) + (+A) + (+A) + (-3A) = 0$.
  • Any linear acoustic artifact or transducer ringing scales strictly with amplitude and cancels out to zero. However, because outer hair cell amplification saturates at higher stimulus levels, the biological cochlear response is nonlinear and does not scale linearly; thus, it survives subtraction and is isolated cleanly.

Temporal Analysis Window & Spectral Decomposition

• Time Window: The analysis window typically spans $2.5\,\text{ms}$ to $20\,\text{ms}$ post-stimulus onset. The initial $0-2.5\,\text{ms}$ interval is discarded (blanked) to avoid residual stimulus ringing.
• Dispersive Traveling Wave Latency: Because the cochlear traveling wave propagates from the high-frequency basal turn to the low-frequency apical turn, TEOAE frequency components appear systematically over time:
  • High-frequency emissions ($4\,\text{kHz}$) arrive early ($3-5\,\text{ms}$ post-stimulus).
  • Mid-frequency emissions ($2\,\text{kHz}$) arrive intermediate ($7-10\,\text{ms}$).
  • Low-frequency emissions ($1\,\text{kHz}$) arrive late ($12-18\,\text{ms}$).
• Signal Averaging: Signals are collected into two alternating sub-buffers (Buffer A and Buffer B). Cross-correlation between Buffer A and Buffer B calculates overall waveform reproducibility, while the algebraic difference $(A - B)$ provides an instantaneous estimate of the background acoustic noise floor.

Clinical Pass / Diagnostic Validity Criteria

To establish a valid, clinically normal TEOAE response:

1. Waveform Reproducibility: Overall cross-correlation $\ge 70-80\%$ over the full time window.
2. Signal-to-Noise Ratio (SNR): An SNR of $\ge 3\,\text{dB}$ to $\ge 6\,\text{dB}$ in at least 3 out of 4 (or 4 out of 5) half-octave frequency bands (typically $1.0, 1.5, 2.0, 3.0, 4.0\,\text{kHz}$).
3. Absolute Amplitude: Minimum emission amplitude exceeding $-10\,\text{dB SPL}$.
4. Noise Floor: Sufficiently low background noise floor (typically $<-5\,\text{dB SPL}$ to $<-10\,\text{dB SPL}$) to ensure that a non-response represents true cochlear dysfunction rather than elevated environmental or physiological noise masking.

Hearing Loss Threshold: TEOAEs are reliably present in ears with normal hearing thresholds ($0-25\,\text{dB HL}$). When sensorineural hearing loss exceeds $30-35\,\text{dB HL}$, TEOAEs are almost universally absent across the affected frequency region.

---

Distortion Product OAEs (DPOAE): Physics & Protocols

When two pure-tone stimuli of different frequencies, designated $f_1$ and $f_2$ ($f_2 > f_1$), are presented simultaneously to a healthy ear, the nonlinear mechanics of the outer hair cells generate intermodulation distortion products at discrete mathematical frequencies not present in the input acoustic signal: $f_{\text{dp}} = (m+n)f_1 \pm (m-n)f_2$

The Cubic Difference Distortion Product ($2f_1 - f_2$)

In the human cochlea, the most robust, clinically reliable distortion product is the cubic difference distortion product, occurring at: $f_{\text{dp}} = 2f_1 - f_2$

For example, if $f_1 = 1000\,\text{Hz}$ and $f_2 = 1220\,\text{Hz}$, the distortion product occurs at: $f_{\text{dp}} = 2(1000) - 1220 = 2000 - 1220 = 780\,\text{Hz}$

Generation Site & Stimulus Optimization

• Site of Generation: The $2f_1 - f_2$ distortion product is generated primarily at the basilar membrane region where the traveling wave envelopes of $f_1$ and $f_2$ maximally overlap. Because the traveling wave for $f_2$ terminates more basally than that of the lower-frequency $f_1$, this critical overlap region is located near the tonotopic characteristic frequency of $f_2$. Consequently, DPOAE clinical results are plotted and interpreted as a function of the $f_2$ frequency.
• Optimal Frequency Ratio ($f_2/f_1$): Extensive empirical research shows that maximum human DP amplitude occurs at an $f_2/f_1$ ratio of approximately $1.21 - 1.22$. Ratios narrower than $1.15$ or wider than $1.30$ cause rapid drop-offs in DP amplitude due to spatial phase cancellation or inadequate traveling wave overlap.
• Asymmetric Stimulus Levels ($L_1/L_2 = 65/55\,\text{dB SPL}$): Presenting equal stimulus levels ($L_1 = L_2 = 65\,\text{dB SPL}$) results in suboptimal interaction because the traveling wave of the lower-frequency tone ($f_1$) is broader and more apical, causing it to over-saturate the overlap region. Setting $L_1$ approximately $10\,\text{dB}$ higher than $L_2$ ($L_1 = 65\,\text{dB SPL}$, $L_2 = 55\,\text{dB SPL}$) matches the effective displacement amplitudes of both tones at the $f_2$ place, maximizing distortion generation.

The DP-Gram & Interpretation Criteria

The primary clinical display for DPOAE testing is the DP-gram, which plots absolute DPOAE amplitude (in $\text{dB SPL}$) and background noise floor (in $\text{dB SPL}$) across discrete test frequencies (typically $f_2 = 1000, 1500, 2000, 3000, 4000, 6000,$ and $8000\,\text{Hz}$).

To consider a DPOAE present and clinically normal at an individual frequency:

1. Signal-to-Noise Ratio (SNR): The absolute emission amplitude must exceed the surrounding noise floor by $\ge 6\,\text{dB}$.
2. Absolute Amplitude: The DP amplitude should fall within the normative range for the system, typically $\ge -5\,\text{dB SPL}$ to $\ge -10\,\text{dB SPL}$ (and well above the system artifact floor).
3. Noise Floor Level: The noise floor must be sufficiently low (typically $\le -10\,\text{dB SPL}$) to confirm that absent emissions are not false negatives driven by ambient room noise or patient breathing.
4. Broadband Pass Rule: For clinical pass in diagnostic screening, normal emissions must be documented across at least 3 to 4 consecutive frequencies.

Hearing Loss Threshold: DPOAEs can be recorded in ears with higher degrees of hearing loss than TEOAEs. While TEOAEs vanish at thresholds $>30-35\,\text{dB HL}$, DPOAEs persist until sensorineural hearing loss exceeds $40-50\,\text{dB HL}$. Above $50\,\text{dB HL}$, DPOAEs are extinguished.

---

Clinical Applications, Case Profiles & Diagnostic Traps

1. Universal Newborn Hearing Screening (UNHS)

OAEs provide an ideal screening modality: they are non-invasive, objective, rapid ($<2\,\text{minutes}$ per infant), and highly sensitive to sensory hearing loss. However, clinicians must navigate distinct screening pitfalls:

• Debris in the External Canal: Vernix caseosa, amniotic fluid, and desquamated epithelial cells in the neonate's canal frequently block the probe ports or create conductive attenuation, yielding false-positive referrals during the first 24-48 hours of life.
• Missed Retrocochlear Lesions: Because OAEs test outer hair cells exclusively, an OAE-only screening protocol fails to detect Auditory Neuropathy Spectrum Disorder (ANSD) or retrocochlear lesions. Consequently, Joint Committee on Infant Hearing (JCIH) guidelines mandate automated ABR (A-ABR) screening for all infants admitted to the Neonatal Intensive Care Unit (NICU) for $>5\,\text{days}$.

2. Differential Diagnosis: Cochlear vs. Retrocochlear & ANSD

The combination of OAEs and auditory evoked potentials isolates the exact anatomical site of lesion:

• Sensory (Cochlear) Loss: Outer hair cell loss matches pure-tone audiometric configuration. OAEs are absent at frequencies exceeding $30-40\,\text{dB HL}$; ABR thresholds track behavioral thresholds.
• Auditory Neuropathy Spectrum Disorder (ANSD): Outer hair cells are functional, yielding robust, intact OAEs and/or a prominent Cochlear Microphonic (CM). Conversely, inner hair cells, ribbon synapses, or Cranial Nerve VIII fibers are disordered, resulting in an absent or severely dyssynchronous ABR, absent acoustic reflexes, and speech recognition scores severely depressed out of proportion to pure-tone thresholds.
• Vestibular Schwannoma (Acoustic Neuroma): In retrocochlear eighth nerve tumors, OAEs remain normal as long as the internal auditory artery (labyrinthine artery) supplying the cochlea is not compressed. If tumor expansion compromises cochlear vascular supply, secondary OHC ischemia occurs, obliterating OAEs secondarily.

3. Ototoxic Drug Surveillance

Ototoxic pharmacotherapies (e.g., cisplatin, carboplatin, aminoglycosides such as amikacin and gentamicin) systematically destroy outer hair cells beginning at the basal turn of the cochlea and progressing apically toward lower frequencies.

• High-frequency DPOAEs (tested up to $8-10\,\text{kHz}$) reveal significant amplitude reductions ($>3-6\,\text{dB}$) weeks before damage spreads into the speech frequencies or manifests as threshold shifts on standard behavioral audiograms.
• Serial DPOAE monitoring allows oncologists to adjust chemotherapy dosing or switch to less ototoxic regimens before permanent communication handicap occurs.

4. Objective Verification in Pseudohypacusis

When patients present with suspected non-organic (functional) hearing loss during medicolegal or disability evaluations, OAEs provide swift, objective refutation:

• If a patient claims a severe or profound sensorineural hearing loss ($>70\,\text{dB HL}$) but exhibits normal, robust DPOAEs across all test frequencies, the cochlea is demonstrably healthy. The true organic hearing thresholds cannot be worse than a mild loss ($35-40\,\text{dB HL}$), directing the audiologist toward Stenger testing and ABR evaluation.

5. Medial Olivocochlear (MOC) Efferent Suppression

The cochlea receives descending efferent innervation via the olivocochlear bundle originating in the superior olivary complex (SOC). The medial olivocochlear (MOC) system consists of thick, myelinated efferent fibers that cross the brainstem and synapse directly onto the basolateral membranes of outer hair cells.

• Mechanism: Presenting low- to moderate-level acoustic stimulation (typically broadband noise at $60-65\,\text{dB SPL}$) to the contralateral ear activates the MOC reflex arc. Efferent fibers release acetylcholine (ACh) onto OHC basolateral receptors. This opens calcium-activated potassium channels, hyperpolarizing the OHC and reducing somatic electromotility.
• Normal Clinical Finding: Contralateral acoustic stimulation reduces (suppresses) ipsilateral TEOAE or DPOAE amplitude by $1.0 - 3.0\,\text{dB}$.
• Diagnostic Pathology: Contralateral OAE suppression is reduced or completely absent in patients with vestibular schwannoma, cerebellopontine angle lesions, auditory neuropathy, and central auditory processing disorders (CAPD), reflecting disruption of brainstem efferent pathways even in ears with normal behavioral hearing thresholds.